COMMUNIQUÉS West-GlobeNewswire

Unnatural Products Raises $45 Million Series B Financing to Advance Macrocyclic Peptide Therapeutics
16/03/2026
Financing led by The Venture Collective with participation from Merck Global Health Innovation Fund, Artis Ventures, First Spark Ventures, argenx, Droia Ventures and existing investors SANTA CRUZ, Calif., March 16, 2026 [...]
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
16/03/2026
Companies Resolve Lawsuit in Delaware BOSTON, March 16, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people [...]
Weight Watchers Announces Fourth Quarter and Full Year 2025 Results
16/03/2026
2025 Total Revenue and Adjusted EBITDA 1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with [...]
OSE Immunotherapeutics Announces its 2026 Financial Calendar
16/03/2026
Nantes, France, March 16, 2026 – 7:30am CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced its financial calendar for 2026. Information Date* 2025 Full-Year Financial Update and Statements [...]
Idorsia announces management change
16/03/2026
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – March 16, 2026 Idorsia Ltd (SIX: IDIA) announces that Dr Srishti Gupta and the Board of Idorsia have mutually agreed that Srishti will step down from [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
16/03/2026
ZUG, Switzerland, March 16, 2026 (GLOBE NEWSWIRE) -- The attached notifications relate to the purchase of ordinary shares by a member of the Company’s Board of Directors. Attachments notification-of-managers-transaction [...]
EssilorLuxottica et Dolce&Gabbana renforcent leur partenariat jusqu’en 2050
16/03/2026
EssilorLuxottica et Dolce&Gabbana renforcent leur partenariat jusqu’en 2050 Paris, France et Milan, Italie (16 mars 2026) - EssilorLuxottica et Dolce&Gabbana annoncent l’extension de leur accord de licence jusqu [...]
SAFE - Modification de la composition du Conseil d'Administration
16/03/2026
Modification de la composition du Conseil d'Administration Fleurieux-sur-l’Arbresle - France - le 16 mars 2026 à 8h. SAFE Group annonce des évolutions significatives au sein de son Conseil d'Administration. Cooptation d [...]
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
16/03/2026
ZUG, Switzerland, March 16, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical [...]
Dvorak Botanicals Launches Low-Dose Hemp-Derived THC Gummies Focused on Mindful Consumption
16/03/2026
Atlanta, GA, March 16, 2026 (GLOBE NEWSWIRE) -- Dvorak Botanicals, a new premium hemp-derived THC brand founded by Atlanta-based entrepreneur Dane Dvorak, has launched with a focus on controlled-dose hemp products that [...]
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
16/03/2026
ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in [...]
GN Store Nord A/S enters into agreement to sell its Hearing business to Amplifon S.p.A. for DKK 17.0 billion
16/03/2026
Today, GN Store Nord A/S (“GN”) has entered into a definitive agreement for the sale of GN’s Hearing business to Amplifon S.p.A. (“Amplifon”), a leading global hearing care retailer. The transaction values the Hearing [...]
BioVersys Receives Green Light from US FDA for BV100 HABP/VABP Phase 3 Pivotal Trial Start
16/03/2026
Ad hoc announcement pursuant to Art. 53 LR BV100 is a potential best-in-class anti-infective agent in treating hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP), caused by [...]
EssilorLuxottica and Dolce&Gabbana further strengthen their partnership through 2050
16/03/2026
EssilorLuxottica and Dolce&Gabbana further strengthen their partnership through 2050 Paris, France and Milan, Italy (16 March 2026) - EssilorLuxottica and Dolce&Gabbana announced today the extension of the [...]
OSE Immunotherapeutics annonce son calendrier financier pour 2026
16/03/2026
Nantes, France, 16 mars 2026 – 7h30 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) annonce aujourd’hui son calendrier financier pour 2026. Information Date* Résultats financiers annuels 2025 29 [...]
Tecan presents 2025 results and provides details on program to reignite profitable growth
16/03/2026
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan presents 2025 results and provides details on program to reignite profitable growth Financial results for the full year 2025 [...]
InnoCare Announces First Healthy Volunteer Dosed in Clinical Trial of Novel VAV1 Degrader ICP-538 in China
16/03/2026
BEIJING, March 15, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Pittsburgh Aesthetics Rebrands as Avere Beauty, Expanding Med Spa Services in Mars, Pennsylvania and Surrounding Areas
16/03/2026
Transition brings enhanced patient experience and Botox, lip filler, and other med spa treatments Avere Beauty Logo PITTSBURGH, March 15, 2026 (GLOBE NEWSWIRE) -- Pittsburgh Aesthetics, a physician-led medical [...]
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
15/03/2026
MELBOURNE, Australia and INDIANAPOLIS, March 16, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the resubmission of a New Drug Application (NDA) to the United [...]

Pages